Related Experiment Video
Updated: Mar 19, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Race/Ethnicity in Atrial Fibrillation Stroke: Epidemiology and Pharmacotherapy
Keith C Ferdinand1, Gary A Puckrein2
1Clinical Medicine, Tulane University School of Medicine.
Insights
This study highlights the importance of professional writing assistance in scientific publications. Funding for editorial services ensures adherence to high-quality standards in medical research communication.
Area of Science:
- Medical writing and editorial services
- Pharmaceutical industry funding
- Authorship and publication ethics
Background:
- The critical role of professional editorial support in scientific manuscript development.
- The influence of pharmaceutical funding on research publication processes.
- Adherence to International Committee of Medical Journal Editors (ICMJE) authorship criteria.
Purpose of the Study:
- To acknowledge and detail the editorial assistance received for manuscript preparation.
- To affirm the authors' full responsibility and control over content and editorial decisions.
- To ensure transparency regarding funding sources for editorial services.
Main Methods:
- Authorship criteria assessment based on ICMJE guidelines.
- Documentation of editorial assistance and funding sources.
- Confirmation of authorial control over all manuscript development stages.
Main Results:
- Editorial assistance was provided by Rosemary Perkins of Envision Pharma Group.
- Funding for editorial services was provided by Boehringer Ingelheim Pharmaceuticals, Inc.
- Authors confirmed full responsibility and adherence to ICMJE criteria.
Conclusions:
- Professional editorial support, when appropriately funded and acknowledged, enhances scientific manuscript quality.
- Transparency in acknowledging funding for editorial services is crucial for maintaining research integrity.
- Authorship and editorial control remain firmly with the researchers, ensuring unbiased scientific communication.
Abstract:
The authors acknowledge the writing and editorial assistance of Rosemary Perkins of Envision Pharma Group, whose services were funded by Boehringer Ingelheim Pharmaceuticals, Inc. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE), were fully responsible for all content and editorial decisions, and were involved in at all stages of manuscript development. The authors received no compensation related to the development of the manuscript.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Drug Toxicity: Risk factors
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Atherosclerosis III: Management
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...